Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Mohamad Sonbol MD

Mohamad Bassam Sonbol MD

Assistant Professor of Medicine, Mayo Clinic School of Medicine; Senior Associate Consultant, Division of Hematology/Oncology, Gastrointestinal Cancer Program, Mayo Clinic, Phoenix, Arizona

Recent Contributions to PracticeUpdate:

  1. 177Lu-DOTA-TATE Plus Long-Acting Octreotide vs High‑Dose Long-Acting Octreotide for Newly Diagnosed, Advanced Grade 2–3, Well-Differentiated, Gastroenteropancreatic Neuroendocrine Tumours

Most Read This Week

Recently Updated